Ropes & Gray represented Sanofi in the transaction. Sanofi announced an agreement to acquire Dren Bio’s deep B-cell depleter program, DR-0201. The targeted bispecific myeloid cell...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Pamlico Capital on the transaction. Pamlico Capital (Pamlico), a leading lower middle-market private equity firm, announced the final close of Pamlico Capital...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Cutera, Inc. on the transaction, and Paul, Weiss advised an ad hoc committee of note holders. McDermott Will & Emery advised Wilmington...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Valspring Capital on the transaction. Valspring Capital (Valspring), a healthcare-focused growth equity firm, announced the final close of the firm’s debut fund,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Coalesce Capital in the transaction, and Locke Lord represented Pearl Meyer and its shareholders. Coalesce Capital, a private equity firm focused on...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Haveli Investments in the transaction, and Paul, Weiss, Rifkind, Wharton & Garrison represented AppViewX. Haveli Investments, an Austin-based technology-focused private equity firm,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised ZeroFox and Haveli Investments, its controlling sponsor, on the transaction. ZeroFox announced the divestment of its subsidiary, IDX, to Kingswood Capital Management....
You must be a Standard 1 Year member to access this content.
Sheppard Mullin is advising OneOncology on the transaction, Debevoise & Plimpton is advising TPG and OneOncology and Ropes & Gray is advising Audax Private Equity. OneOncology,...
You must be a Standard 1 Year member to access this content.
Ropes and Gray and Winston & Strawn advised Chartis and Audax Private Equity on the transaction, and Kirkland & Ellis advised Blackstone. Chartis, a leading healthcare...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Amylyx Pharmaceuticals in the transaction and Sidley Austin represented Eiger BioPharmaceuticals. Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (Amylyx) announced the acquisition of a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Skydance and the Investor Group on the transaction; Sullivan & Cromwell advised RedBird Capital Partners; Ropes & Gray advised National Amusements; Cravath,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Ginkgo Bioworks in the transaction. Ginkgo Bioworks (NYSE: DNA) announced its acquisition of AgBiome’s platform assets in agricultural biologics. The assets will be integrated into...
You must be a Standard 1 Year member to access this content.
